Ginseng saponin H extract and preparation method thereof

A technology of ginsenosides and total ginsenosides is applied in the directions of drug combinations, pharmaceutical formulations, plant raw materials, etc., which can solve problems such as poor effect, and achieve the effects of novel use, high yield and convenient operation.
CN102058643AInactive Publication Date: 2011-05-18TIANJIN TASLY PHARMA CO LTD
3 Cites 2 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
TIANJIN TASLY PHARMA CO LTD
Publication Date
2011-05-18
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a traditional Chinese medicine extract and a preparation method thereof, in particular to a Ginseng saponin H extract and a preparation method thereof. In the extract, the content of protodioscin is not less than 60 percent based on that of Ginseng saponin Rh2 and the content of the Ginseng saponin Rh1 and the Ginseng saponin Rh2 is not less than 30 percent.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a traditional Chinese medicine extract and a preparation method thereof, in particular to a ginsenoside H extract and its preparation. Background technique

[0002] Ginseng has many reports in the treatment of cardiovascular and cerebrovascular diseases.

[0003] Ginsenoside can treat coronary heart disease and ischemic stroke.

[0004] Ginsenoside H is the secondary saponin produced by hydrolysis of ginsenoside components, and then purified by silica gel column chromatography to obtain the effective part-H group saponin. The main ingredient of the drug is also the main anti-cancer active ingredient of the drug. Pharmacodynamic studies have shown that: ginsenoside Rh2 has a significant and specific inhibitory effect on the proliferation of cancer cells such as liver cancer, melanoma B16, cervical cancer and sarcoma S180. Its mechanism of action is as follows: in the process of cancer cell proliferation, through the action of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More